Richard B. Slansky - 18 Mar 2026 Form 3 Insider Report for Genenta Science S.p.A. (GNTA)

Role
Chief Financial Officer
Signature
/s/ Richard B. Slansky
Issuer symbol
GNTA
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 16:05:52 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SLANSKY RICHARD B Chief Financial Officer 13973 CARRIAGE ROAD, POWAY, /s/ Richard B. Slansky 18 Mar 2026 0001224981

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GNTA Ordinary Shares 19,947 18 Mar 2026 Direct
holding GNTA American Depositary Shares ("ADSs") 2,200 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 127,520 $4.76 Direct F2
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 100,000 $3.08 Direct F3
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 60,000 $4.36 Direct F4
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 15,338 $4.36 Direct F5
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 7,669 $4.36 Direct F6
holding GNTA Stock Option (right to buy) 18 Mar 2026 ADSs 120,000 $1.48 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents one ordinary share, no par value, of the Issuer.
F2 The stock options vest in two parts: options on 22,884 shares vested immediately and became exercisable on July 21, 2022; and options on 104,636 shares vest in equal monthly installments over three-years beginning July 21, 2022.
F3 The options vest in equal monthly installments over three-years beginning July 1, 2024.
F4 The stock options vest in equal monthly installments over three-years beginning June 4, 2025.
F5 The stock options were issued in place of a cash bonus for 2023 and became fully vested and exercisable on June 4, 2025.
F6 The stock options were issued in place of a cash bonus for 2024 and became fully vested and exercisable on June 4, 2025.
F7 The stock options vest in equal monthly installments over three-years beginning December 18, 2025.